Table 3.
Demographic characteristic of RMR-TB patients, Iran*
| Group receiving (DOTS) | Nationality | Mean ± SD age, years | M/F | History of TB | Close or family contact | Spoligotypes | ||
|---|---|---|---|---|---|---|---|---|
| Iranian | Afghani | Other | ||||||
| A (positive after 9 months) | 20 | 6 | 3 | 47.2 ± 12.5 | 18/11 | 4 | 7 | Beijing (6), CAS1_KILI(10), H4 (5), H3 (1), T1 (3), MANU2 (1), Unknown (1), S (1), LAM (1) |
| B (positive after 9 months) | 18 | 9 | – | 39.7 ± 6.9 | 19/8 | 2 | 5 | Beijing (1), CAS1_KILI (7), CAS1_DELHI (3), H4 (4), H3 (1), T1 (2), MANU2 (1), Unknown (5), LAM (1), S (1) |
| C (positive after 4 months) | 17 | 8 | – | 40.5 ± 11.3 | 13/12 | 3 | 3 | CAS1_KILI (8), H4 (6), H3 (1), T1 (7), Unknown (1), U (2) |
| D (positive after 2 months) | 6 | 5 | – | 37.0 ± 16 | 7/4 | 4 | 3 | CAS1_KILI (6), U (3), H4 (2) |
| Total | 61 (66.3%) | 28 (30.4%) | 3 (3.2%) | 41.1 ± 11.6 | 57/35 | 13 (14.1%) | 18 (19.5%) | CAS (32; 34.7%), H (20; 21.7%), T1(14; 15.2%), Beijing (7; 11.1%), U (5; 5.4%, Unknown (7; 7.6% LAM (2; 2.1%), MANU 2 (2; 2.1%), S (2; 2.1%) |
*
RMR-TB = rifampin-monoresistant tuberculosis.